Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131).

Nishio S, Aihara S, Shimokawa M, Fujishita A, Taniguchi S, Hachisuga T, Yanazume S, Kobayashi H, Murakami F, Numa F, Kotera K, Okura N, Toki N, Yokoyama M, Ushijima K.

J Gynecol Oncol. 2018 Sep;29(5):e77. doi: 10.3802/jgo.2018.29.e77. Epub 2018 May 15.

2.

[Tentorial Dural Arteriovenous Fistula Presenting with Ocular Symptoms:A Case Report].

Toki N, Masuo O, Nishibayashi H, Yako R, Kawaguchi T, Izawa D, Nakao N.

No Shinkei Geka. 2018 Mar;46(3):219-225. doi: 10.11477/mf.1436203708. Japanese.

PMID:
29567872
3.

New diagnostic criteria of colposcopy for uterine cervix neoplasia.

Kashimura M, Matsuura Y, Kawagoe T, Toki N, Hachisuga T.

J Obstet Gynaecol Res. 2017 Feb;43(2):339-344. doi: 10.1111/jog.13199. Epub 2016 Dec 8.

PMID:
27928861
4.

Factors predicting successful discontinuation of continuous renal replacement therapy.

Katayama S, Uchino S, Uji M, Ohnuma T, Namba Y, Kawarazaki H, Toki N, Takeda K, Yasuda H, Izawa J, Tokuhira N, Nagata I; Japanese Society of Education for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group.

Anaesth Intensive Care. 2016 Jul;44(4):453-7.

5.

External Validation for Acute Kidney Injury Severity Scores: A Multicenter Retrospective Study in 14 Japanese ICUs.

Ohnuma T, Uchino S, Toki N, Takeda K, Namba Y, Katayama S, Kawarazaki H, Yasuda H, Izawa J, Uji M, Tokuhira N, Nagata I; JSEPTIC (Japanese Society for Physicians and Trainees in Intensive Care) Clinical Trial Group.

Am J Nephrol. 2015;42(1):57-64.

PMID:
26337793
6.

Sepsis may not be a risk factor for mortality in patients with acute kidney injury treated with continuous renal replacement therapy.

Nagata I, Uchino S, Tokuhira N, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Yasuda H, Izawa J, Uji M; JSEPTIC (Japanese Society for Physicians Trainees in Intensive Care) Clinical Trial Group.

J Crit Care. 2015 Oct;30(5):998-1002. doi: 10.1016/j.jcrc.2015.06.021. Epub 2015 Jun 26.

PMID:
26220246
7.

The lower limit of intensity to control uremia during continuous renal replacement therapy.

Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Izawa J, Tokuhira N, Nagata I; Japanese Society for Physicians and Trainees in Intensive Care Clinical Trial Group.

Crit Care. 2014 Oct 7;18(5):539. doi: 10.1186/s13054-014-0539-4.

8.

[Uterine cervical cancer screening in kitakyushu city: present and future].

Matsuura Y, Oka H, Yamagata K, Kikuchi J, Inoue I, Ohkubo N, Toki N, Kawagoe T, Hachisuga T, Kashimura M.

J UOEH. 2014 Sep 1;36(3):205-15. Japanese.

9.

Validity of low-intensity continuous renal replacement therapy*.

Uchino S, Toki N, Takeda K, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Yasuda H, Izawa J, Uji M, Tokuhira N, Nagata I; Japanese Society for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group.

Crit Care Med. 2013 Nov;41(11):2584-91. doi: 10.1097/CCM.0b013e318298622e.

PMID:
23939357
10.

Who may not benefit from continuous renal replacement therapy in acute kidney injury?

Kawarazaki H, Uchino S, Tokuhira N, Ohnuma T, Namba Y, Katayama S, Toki N, Takeda K, Yasuda H, Izawa J, Uji M, Nagata I; JSEPTIC (Japanese Society for Physicians Trainees in Intensive Care) Clinical Trial Group.

Hemodial Int. 2013 Oct;17(4):624-32. doi: 10.1111/hdi.12053. Epub 2013 May 7.

PMID:
23651363
11.

Trends in the demographic and clinicopathological characteristics in Japanese patients with endometrial cancer, 1990-2010.

Honda T, Urabe R, Kurita T, Kagami S, Kawagoe T, Toki N, Matsuura Y, Hachisuga T.

Int J Womens Health. 2012;4:207-12. doi: 10.2147/IJWH.S31541. Epub 2012 May 14.

12.

Furuncle of the nose.

Watanabe K, Toki N.

Acta Otorrinolaringol Esp. 2013 Sep-Oct;64(5):382. doi: 10.1016/j.otorri.2012.02.011. Epub 2012 Apr 30. English, Spanish. No abstract available.

13.

Prognostic significance of BAF57 expression in patients with endometrial carcinoma.

Kagami S, Kurita T, Kawagoe T, Toki N, Matsuura Y, Hachisuga T, Matsuyama A, Hashimoto H, Izumi H, Kohno K.

Histol Histopathol. 2012 May;27(5):593-9. doi: 10.14670/HH-27.593.

PMID:
22419023
14.

Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer.

Kurita T, Izumi H, Kagami S, Kawagoe T, Toki N, Matsuura Y, Hachisuga T, Kohno K.

Cancer Sci. 2012 Feb;103(2):239-444. doi: 10.1111/j.1349-7006.2011.02156.x. Epub 2011 Dec 23.

15.

Site-specific isotope labeling of long RNA for structural and mechanistic studies.

Kawahara I, Haruta K, Ashihara Y, Yamanaka D, Kuriyama M, Toki N, Kondo Y, Teruya K, Ishikawa J, Furuta H, Ikawa Y, Kojima C, Tanaka Y.

Nucleic Acids Res. 2012 Jan;40(1):e7. doi: 10.1093/nar/gkr951. Epub 2011 Nov 12.

16.

Metabolomic profiling of uremic solutes in CKD patients.

Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T.

Hypertens Res. 2010 Sep;33(9):944-52. doi: 10.1038/hr.2010.113. Epub 2010 Jul 8. Erratum in: Hypertens Res. 2010 Oct;33(10):1089.

PMID:
20613759
17.

Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance.

Toki N, Kagami S, Kurita T, Kawagoe T, Matsuura Y, Hachisuga T, Matsuyama A, Hashimoto H, Izumi H, Kohno K.

Virchows Arch. 2010 Apr;456(4):387-93. doi: 10.1007/s00428-010-0895-7. Epub 2010 Mar 16.

18.

[Uterine cervical cancer screening in Japan: today and future].

Matsuura Y, Kawagoe T, Toki N, Hachisuga T, Kashimura M.

J UOEH. 2009 Jun 1;31(2):181-93. Japanese.

PMID:
19530563
19.

Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.

Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T.

Cancer Res. 2009 Jun 1;69(11):4918-25. doi: 10.1158/0008-5472.CAN-08-4806. Epub 2009 May 19.

20.

[The efficacy and safety of indisetron hydrochloride for the management of nausea/vomiting caused by chemotherapy for gynecologic cancer].

Ushijima K, Wake N, Kobayashi H, Hachisuga T, Toki N, Masuzaki H, Kotera K, Kawarabayashi T, Emoto M, Kamura T.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1169-73. Japanese.

PMID:
18633256
21.

A genome-wide gain-of function analysis of rice genes using the FOX-hunting system.

Nakamura H, Hakata M, Amano K, Miyao A, Toki N, Kajikawa M, Pang J, Higashi N, Ando S, Toki S, Fujita M, Enju A, Seki M, Nakazawa M, Ichikawa T, Shinozaki K, Matsui M, Nagamura Y, Hirochika H, Ichikawa H.

Plant Mol Biol. 2007 Nov;65(4):357-71. Epub 2007 Oct 10.

PMID:
17929174
22.

Evaluation of pregnancy-related cells in endometrial cytology.

Kashimura Y, Fukuda J, Toki N, Doki W, Kashimura M.

Acta Cytol. 2007 May-Jun;51(3):407-11.

PMID:
17536543
23.

Long-standing complications after treatment for cancer of the uterine cervix--clinical significance of medical examination at 5 years after treatment.

Matsuura Y, Kawagoe T, Toki N, Tanaka M, Kashimura M.

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):294-7.

PMID:
16445648
24.

[Risk factors and prevention of uterine cervical cancer].

Kawagoe T, Toki N, Matsuura Y, Kashimura M.

Nihon Rinsho. 2004 Oct;62 Suppl 10:233-6. Review. Japanese. No abstract available.

PMID:
15535242
25.

[Epidemiology of uterine cervix cancer].

Kashimura M, Kawagoe T, Matsuura Y, Toki N.

Nihon Rinsho. 2004 Oct;62 Suppl 10:57-60. Review. Japanese. No abstract available.

PMID:
15535205
26.

Selective oxidation of alcohols at the benzylic position by benzeneseleninic anhydride.

Toki N, Satoh T.

Chem Pharm Bull (Tokyo). 2004 Aug;52(8):1009-12.

27.

Enhancement of mitochondrial oxidative stress and up-regulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae.

Shibata E, Nanri H, Ejima K, Araki M, Fukuda J, Yoshimura K, Toki N, Ikeda M, Kashimura M.

Placenta. 2003 Jul;24(6):698-705.

PMID:
12828928
28.

Myxoid leiomyosarcoma of the uterus with subsequent pregnancy and delivery.

Kagami S, Kashimura M, Toki N, Katuhata Y.

Gynecol Oncol. 2002 Jun;85(3):538-42. Review.

PMID:
12051888
29.

Glassy cell carcinoma of the uterine cervix: combination chemotherapy with paclitaxel and carboplatin in recurrent tumor.

Matsuura Y, Murakami N, Nagashio E, Toki N, Kashimura M.

J Obstet Gynaecol Res. 2001 Jun;27(3):129-32.

PMID:
11561828
30.

Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects.

Shibata E, Ejima K, Nanri H, Toki N, Koyama C, Ikeda M, Kashimura M.

Placenta. 2001 Jul;22(6):566-72.

PMID:
11440545
31.

Clinical significance of tumor size in stage IB and II carcinoma of the uterine cervix.

Kawagoe T, Kashimura M, Matsuura Y, Sugihara K, Toki N, Aoki T.

Int J Gynecol Cancer. 1999 Sep;9(5):421-426.

PMID:
11240805
32.

Myxoid leiomyosarcoma of the uterus. Report of a case with cytologic findings.

Toki N, Kashimura M, Hasegawa T, Fukuoka K, Kawagoe T, Sugihara K, Koyama C, Hisaoka M.

Acta Cytol. 2000 May-Jun;44(3):415-9.

PMID:
10834002
33.

Sarcoma botryoides of the cervix. Report of a case with cytopathologic findings.

Matsuura Y, Kashimura M, Hatanaka K, Toki N, Sugihara K.

Acta Cytol. 1999 May-Jun;43(3):475-80.

PMID:
10349384
34.
35.

Low grade cervical intraepithelial neoplasia associated with human papillomavirus infection. Long-term follow-up.

Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M.

Acta Cytol. 1998 May-Jun;42(3):625-30.

PMID:
9622679
36.

The significance of peritoneal cytology in uterine cervix and endometrial cancer.

Kashimura M, Sugihara K, Toki N, Matsuura Y, Kawagoe T, Kamura T, Kaku T, Tsuruchi N, Nakashima H, Sakai H.

Gynecol Oncol. 1997 Dec;67(3):285-90.

PMID:
9441776
37.

Cytologic analysis of primary stomach adenocarcinoma metastatic to the uterine cervix.

Matsuura Y, Saito R, Kawagoe T, Toki N, Sugihara K, Kashimura M.

Acta Cytol. 1997 Mar-Apr;41(2):291-4.

PMID:
9100756
38.

Cellular characteristics of Arias-Stella reaction in ectopic pregnancy. Immunocytochemical studies with epithelial membrane antigen and vimentin.

Toki N, Kawagoe T, Matsuura Y, Sugihara K, Kashimura M, Kashimura Y.

Acta Cytol. 1997 Mar-Apr;41(2):285-90.

PMID:
9100755
39.

[A case of large cystic adenomyosis of the uterus preoperatively diagnosed as an ovarian cancer].

Nagashio E, Toki N, Koyama C, Kashimura M.

Nihon Sanka Fujinka Gakkai Zasshi. 1996 Oct;48(10):901-3. Japanese. No abstract available.

PMID:
8921525
40.

Early cervical neoplasia confirmed by conization: diagnostic accuracy of cytology, colposcopy and punch biopsy.

Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M.

Acta Cytol. 1996 Mar-Apr;40(2):241-6.

PMID:
8629405
41.

Immunohistochemical distribution of surfactant apoproteins in hypoplastic lungs of nonimmunologic hydrops fetalis.

Toki N, Sueishi K, Minamitani M, Maeda H, Nakano H, Suzuki Y.

Hum Pathol. 1995 Nov;26(11):1252-9.

PMID:
7590701
42.
43.

Cytology of vulvar squamous neoplasia.

Kashimura M, Matsuura Y, Kawagoe T, Toki N, Sugihara K.

Acta Cytol. 1993 Nov-Dec;37(6):871-5.

PMID:
8249504
44.

[Problems in Papanicolaou classification].

Kashimura M, Matsuura Y, Kawagoe T, Sugihara K, Toki N.

J UOEH. 1993 Mar 1;15(1):37-43. Japanese.

PMID:
8480094
45.

[An autopsy case of citrullinemia type II complicated with chronic pancreatitis].

Tatsumoto T, Yamamoto K, Kudo J, Kondo H, Shimamura R, Hirata Y, Ishibashi H, Niho Y, Toki N, Nakashima Y, et al.

Fukuoka Igaku Zasshi. 1992 Jan;83(1):43-50. Japanese.

PMID:
1547989
46.

Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.

Kira J, Itoyama Y, Koyanagi Y, Tateishi J, Kishikawa M, Akizuki S, Kobayashi I, Toki N, Sueishi K, Sato H, et al.

Ann Neurol. 1992 Jan;31(1):39-45.

PMID:
1543349
47.

Microscopic ovarian metastasis of the uterine cervical cancer.

Toki N, Tsukamoto N, Kaku T, Toh N, Saito T, Kamura T, Matsukuma K, Nakano H.

Gynecol Oncol. 1991 Apr;41(1):46-51.

PMID:
2026359
48.

Distribution of basement membrane antigens in the uterine cervical adenocarcinomas: an immunohistochemical study.

Toki N, Kaku T, Tsukamoto N, Matsumura M, Saito T, Kamura T, Matsuyama T, Nakano H.

Gynecol Oncol. 1990 Jul;38(1):17-21.

PMID:
2354821
49.

Early adenocarcinoma of the uterine cervix--its histologic and immunohistologic study.

Matsukuma K, Tsukamoto N, Kaku T, Matsumura M, Toki N, Toh N, Nakano H.

Gynecol Oncol. 1989 Oct;35(1):38-43.

PMID:
2676752
50.

[Study on the treatment of malignant vulvar diseases].

Saito T, Tsukamoto N, Toki N, Sugihara K, Toh N, Kaku T, Kamura T, Matsukuma K, Matsuyama T, Nakano H.

Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1683-8. Japanese.

PMID:
2730067

Supplemental Content

Support Center